Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in Canada
INTRODUCTION: Posaconazole prophylaxis in high-risk neutropenic patients prevents invasive fungal infection (IFI). An economic model was used to assess the cost effectiveness of posaconazole from a Canadian health care system perspective.
Saved in:
| Main Authors: | Amir A Tahami Monfared, Amy K O’Sullivan, Coleman Rotstein, George Papadopoulos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2012/583630 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combinations of posaconazole and tacrolimus are effective against infections with azole-resistant Aspergillus fumigatus
by: Eliane Vanhoffelen, et al.
Published: (2025-04-01) -
Successful Treatment of Chronic Mucocutaneous Candidiasis Caused by Azole-Resistant Candida albicans with Posaconazole
by: Davide Firinu, et al.
Published: (2011-01-01) -
Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants
by: Santiago Grau, et al.
Published: (2015-10-01) -
Effectiveness of Posaconazole in Recalcitrant Fungal Keratitis Resistant to Conventional Antifungal Drugs
by: A. Altun, et al.
Published: (2014-01-01) -
Comparative pharmacoeconomic analysis of posaconazole therapy in tablet form and in suspension for invasive fungal infections prevention
by: I. S. Krysanov, et al.
Published: (2021-06-01)